HU0700809D0 - Racemisation process for producing methyl (r,s)-(+)-alpha-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridin-5(4h)-acetate hydrogene sulfate intermediate - Google Patents
Racemisation process for producing methyl (r,s)-(+)-alpha-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridin-5(4h)-acetate hydrogene sulfate intermediateInfo
- Publication number
- HU0700809D0 HU0700809D0 HU0700809A HUP0700809A HU0700809D0 HU 0700809 D0 HU0700809 D0 HU 0700809D0 HU 0700809 A HU0700809 A HU 0700809A HU P0700809 A HUP0700809 A HU P0700809A HU 0700809 D0 HU0700809 D0 HU 0700809D0
- Authority
- HU
- Hungary
- Prior art keywords
- dihydrothieno
- pyridin
- chlorophenyl
- alpha
- acetate
- Prior art date
Links
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 title 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 title 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0700809A HUP0700809A2 (en) | 2007-12-14 | 2007-12-14 | Racemisation process for producing methyl (r,s)-(+)-alpha-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridin-5(4h)-acetate hydrogene sulfate intermediate |
| PCT/HU2008/000148 WO2009077797A1 (en) | 2007-12-14 | 2008-12-11 | Racemization process for the preparation of an intermediate of clopidogrel hydrogen sulphate |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0700809A HUP0700809A2 (en) | 2007-12-14 | 2007-12-14 | Racemisation process for producing methyl (r,s)-(+)-alpha-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridin-5(4h)-acetate hydrogene sulfate intermediate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HU0700809D0 true HU0700809D0 (en) | 2008-02-28 |
| HUP0700809A2 HUP0700809A2 (en) | 2009-11-30 |
Family
ID=89987939
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0700809A HUP0700809A2 (en) | 2007-12-14 | 2007-12-14 | Racemisation process for producing methyl (r,s)-(+)-alpha-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridin-5(4h)-acetate hydrogene sulfate intermediate |
Country Status (2)
| Country | Link |
|---|---|
| HU (1) | HUP0700809A2 (hu) |
| WO (1) | WO2009077797A1 (hu) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111166745A (zh) * | 2020-01-19 | 2020-05-19 | 成都施贝康生物医药科技有限公司 | 含消旋氧吡格雷或其盐的组合物及应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL166593A0 (en) * | 2002-08-02 | 2006-01-15 | Racemization and enantiomer separation of clopidogrel |
-
2007
- 2007-12-14 HU HU0700809A patent/HUP0700809A2/hu unknown
-
2008
- 2008-12-11 WO PCT/HU2008/000148 patent/WO2009077797A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2009077797A1 (en) | 2009-06-25 |
| HUP0700809A2 (en) | 2009-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2007125544A3 (en) | Process for the preparation of polymorphic forms of clopidogrel hydrogen sulfate | |
| ZA201005554B (en) | Furo-and thieno[3,2-c]pyridines | |
| IL185510A0 (en) | Fused thieno [2,3-b] pyridine and thiazolo [5,4-b] pyridine compounds for inhibiting ksp kinesin activity | |
| ZA200806313B (en) | Pyrrolo [3,2-c]pyridine-4-one 2-indolinone protein kinase inhibitors | |
| IL189667A0 (en) | 4-amino-thieno[3,2-c]pyridine-7-carboxylic acid derivatives | |
| ZA200802690B (en) | Thieno[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors | |
| ZA200504238B (en) | Thieno[3,2-b]pyridine-6-carbonitriles and thienoo[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors | |
| SI1740593T1 (sl) | Postopek za pripravo polimorfne oblike I klopidogrel hidrogen sulfata | |
| PL2112155T3 (pl) | Wodorosiarczan (VI) 2-acetoksy-5-(α-cyklopropylokarbonylo-2-fluorobenzylo)-4,5,6,7-tetrahydrotieno[3,2-c]pirydyny i sposób jego otrzymywania | |
| SI1513846T1 (sl) | Postopek za pripravo olanzapina form I | |
| EP1651646A4 (en) | NEW PROCESS FOR THE PREPARATION OF (+) - (S) -CLOPIDOGREL BISULFATE OF FORM I | |
| IL192825A0 (en) | A PROCESS FOR THE PREPARATION OF POLYMORPH FORM I OF (S)-(+)-METHYL-ßé?- (2-CHLOROPHENYL)-6,7-DYHIDRO-THIENO-[3,2-C]PYRIDINE-5(4H)-ACETATE HYDROGEN SULFATE | |
| IL177805A0 (en) | A method for preparing thieno[3,2-c]pyridine derivatives | |
| PL354642A1 (en) | Method of manufacture of alanzapine, new derivative of n-demethyl olanzapine and method of manufacture of new derivative of n-demethyl olanzapine | |
| ZA201000627B (en) | 2-(2-oxoindoline-3-ylidene)methyl-5-(2-hydroxy-3-morpholin-4-yl-propyl)-6,7-dihydro-1h-pyrrol[3,2-c]pyridine-4(5h)-one compounds and use as protein kinase inhibitors | |
| ZA200608569B (en) | Polymorphic forms of methyl (+)-(S)-alpha- (2-chlorophenyl)-6, 7-dinydrothieno[3,2-C] pyridine-5(4H) acetate hydrobromide, clopidrogel hydrobromide | |
| EP1742629A4 (en) | METHOD FOR TREATING ALCOHOLISM | |
| UA84335C2 (ru) | Клопидогрель и его полиморфные формы | |
| WO2007087555A3 (en) | Novel polymorph 'form e ' of olanzapine (2-methyl-4- (4-methyl-1-piperazinyl) -10h-thieno [2, 3-b] [1, 5] benzodiazepine) and preparation of the anhydrous non-solvated crystalline polymorphic 'form i' of olanzapine from the polymorphic olanzapine 'form e' | |
| PL380849A1 (pl) | Krystaliczna postać racemicznego -(2-chlorofenylo)-6,7-dihydrotieno[3,2-c]pirydylo-5(4H)-octanu metylu, sposób jej wytwarzania i zastosowanie | |
| ZA200707302B (en) | Fused thieno [2,3-B] pyridine and thiazolo [5,4-B] pyridine compounds for inhibiting KSP kinesin activity | |
| WO2008108742A3 (en) | Polymorphic forms of clopidogrel hydrobromide | |
| EA201290535A1 (ru) | Способ получения фармацевтических соединений и промежуточных соединений | |
| WO2005003138A3 (en) | Process for the preparation of amorphous form of a platelet aggregation inhibitor drug | |
| SG113595A1 (en) | New benzo[b]chromeno-naphthyridin-7-one and pyrano[2',3':7,8] quino[2,3-b]quinoxalin-7-one compounds, process for their preparation and pharmaceutical compositions containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA9A | Lapse of provisional patent protection due to relinquishment or protection considered relinquished |